Cervical cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age >= 18 years, = 10mm, CT scan short diameter of lymph node lesion >= 15mm); 6. No contraindications for close treatment; 7. No serious medical complications; 8. Patients voluntarily joined the study and signed informed consent with good compliance and follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients with local cervical mass larger than 4 cm; 2. Patients with parauuterine invasion up to the pelvic wall, or with definite pathological evidence of vesicorectal invasion; 3. Severe vaginal stenosis or too short to implant a multi-channel transmitter; 4. Those who have a history of psychotropic drug abuse and cannot get rid of it or have mental disorders; 5. The investigator determines other conditions that may affect the conduct of the clinical study and the determination of the study results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HR-CTV D90;the rectum dose of D2cc;the rectum dose of D1cc;the bladder dose of D2cc;the bladder dose of D1cc;the sigmoid colon dose of D2cc;the sigmoid colon dose of D1cc;Response Evaluation in Solid Tumors;Acute genitourinary toxici-ties;acute proctitis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overdose index;Dose nonuniformity index;Dose homogeneity index;Conformity index;the sigmoid colon dose of D0.01cc;the sigmoid colon dose of D0.1cc;the bladder dose of D0.01cc;the bladder dose of D0.1cc;the rectum dose of D0.01cc;the rectum dose of D0.1cc; | — |
Countries
China
Contacts
Affiliated Hospital of Guizhou Medical University